Rebiotix competitorsClear all

Rebiotix's top competitors include VBI Vaccines, Harbour Antibodies, GrayBug and PellePharm.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Rebiotix
Rebiotix
Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome.
VBI Vaccines
VBI Vaccines
VBI Vaccines is a biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology.
Harbour Antibodies
Harbour Antibodies
Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.
GrayBug
GrayBug
GrayBug is a biotechnology company developing technologies to treat eye diseases.
PellePharm
PellePharm
PellePharm, Inc. operates in the biotechnology industry.
Founding Date
Founding Date
2011
Founding Date
2001
Founding Date
2006
Founding Date
2011
Founding Date
2012
Type
Type
Private
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Saint Paul, US HQ
Locations
Cambridge, US HQ
Ottawa, CA
Rehovot, IL
Locations
Newton, US HQ
Locations
Redwood City, US HQ
Baltimore, US
Locations
San Francisco, US HQ
Employees
Employees
841% increase
Employees
12314% increase
Employees
1
Employees
313% increase
Employees
5
Twitter followers
Twitter followers
2.3 k
Twitter followers
2.3 k
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
19
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
0.6
Average likes per tweet (last 30 days)
17
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
78.95%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
335004
Alexa Website Rank
171128
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Employee Rating
Employee Rating
3
Employee Rating
2.5
Employee Rating
N/A
Employee Rating
4
Employee Rating
N/A

Funding

Latest funding round
Latest funding round
$ 25m (over 7 years ago)
Latest funding round
N/A
Latest funding round
$ 3.2m (over 8 years ago)
Latest funding round
$ 80m (over 2 years ago)
Latest funding round
$ 70m (about 3 years ago)
Total funding raised
Total funding raised
$ 27.8m
Total funding raised
N/A
Total funding raised
$ 3.2m
Total funding raised
$ 128.5m
Total funding raised
$ 81.4m
For sources of this data, please see the company profile

View company profiles

VBI Vaccines
HQ
Cambridge, US
Employees
123↑ 14% increase

VBI Vaccines is a biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology.

View company
Harbour Antibodies
HQ
Newton, US
Employees
1

Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.

View company
GrayBug
HQ
Redwood City, US
Employees
31↑ 3% increase

GrayBug is a biotechnology company developing technologies to treat eye diseases.

View company
PellePharm
HQ
San Francisco, US
Employees
5

PellePharm, Inc. operates in the biotechnology industry.

View company